People on the Move Archives - Page 33 of 148

instED Names Don Stiffler Chief Executive Officer

December 29, 2025

Agenus Reports Durable Responses in Refractory Ovarian Cancer With Botensilimab and Balstilimab

December 23, 2025

Quanterix Nature Study Redefines Prevalence of Alzheimer’s Disease Neuropathology in General Population

December 22, 2025

THIS WEEK'S STORIES

QurAlis Reports Early Clinical Evidence of Target Engagement for QRL-101 in ALS Patients

December 29, 2025

Verastem Oncology Discontinues RAMP 203 Trial to Prioritize KRAS G12D Program

December 30, 2025

Biobeat Secures $50 Million to Replace the Blood Pressure Cuff with Wearable Patch Technology

December 31, 2025

ABOUT US

Life Science Times is New England’s premier life sciences publication, covering the Pharma, Biotech, MedTech and Public Health sectors nationwide with a special focus on New England. Updated daily, we cover the latest news in everything else that touches any rubric of the rapidly growing life sciences industry.

People on the Move

PharmaEssentia USA Appoints Jeffrey Williams as Independent Director

instED Names Don Stiffler Chief Executive Officer

PureTech Appoints Robert Lyne as Chief Executive Officer

Element Care Appoints Andrew Zamansky as Chief Financial Officer

Calluna Pharma Appoints Gijs van den Brink, MD, PhD, as Independent Director

Most Read

Delcath Data Reveals HEPZATO KIT Benefits Patients Across All Subgroups

Biobeat Secures $50 Million to Replace the Blood Pressure Cuff with Wearable Patch Technology

Verastem Oncology Discontinues RAMP 203 Trial to Prioritize KRAS G12D Program

Vicarious Surgical Partners With Global Software Firm to Streamline Development Operations

EDITOR PICKS

instED Names Don Stiffler Chief Executive Officer

Agenus Reports Durable Responses in Refractory Ovarian Cancer With Botensilimab and Balstilimab

Quanterix Nature Study Redefines Prevalence of Alzheimer’s Disease Neuropathology in General Population

THIS WEEK'S STORIES

QurAlis Reports Early Clinical Evidence of Target Engagement for QRL-101 in ALS Patients

Verastem Oncology Discontinues RAMP 203 Trial to Prioritize KRAS G12D Program

Biobeat Secures $50 Million to Replace the Blood Pressure Cuff with Wearable Patch Technology

POPULAR CATEGORY

ABOUT US

FOLLOW US